GovChime
UEI: HEJ6JKLSV3E7 • CAGE: 8PFQ2

BIOSYNCHRONICITY CORPORATION (WA)

Registration facts

SAM.gov registration as of

SAM.gov registration
Active
Registration expiration date Jun 5, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Jun 9, 2020 (6 years)
Location
Bellevue, WA
State of incorporation
Washington
Purpose of registration
All Awards

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI HEJ6JKLSV3E7. GovChime does not check exclusions.

Performance

Capabilities

SBA certifications

  • SBA-Certified Women-Owned Small Business, certified Jun 6, 2023

Business types self-reported in SAM.gov registration:

  • Women-Owned Small Business
  • Women-Owned Business

Product and service codes (PSC)

  • 6509DRUGS AND BIOLOGICALS, VETERINARY USE
  • 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Federal Capability Statement

BioSynchronicity Corporation is a Woman Owned Small Business (WOSB) focused on Biotechnology Research and Development, design and manufacturing of diagnostics for the medical, dental, and veterinary industries, as well as laboratory services, next generation genomic sequencing, including preventative early cancer screening, surveillance, and recurrence testing. Our flagship BioSynchronicity C-Sync™ Lateral Flow Assay technology platform was launched in 2020. Our C-Sync™ COVID 19 multi target rapid antigen test detecting both nucleocapsid and spike proteins was granted an EUA by the FDA in 2023. A new innovative multiplex combination test for COVID and Flu, as well as an assay for Avian Influenza are in development. Graphene based electrochemical biosensor assays for the early quantitative detection of infectious diseases and other biomarkers are in the pipeline.

Capabilities & Services

in vitro
in vitro diagnostic
diagnostic
IVD
COVID
19
rapid
antigen
test
lateral flow assay
LFA
animal
drug
opioid
oral
cancer
laboratory
EUA
Flu
multiplex
multi-target
multitarget
spike
protein
nucleocapsid
Fentanyl
Xylazine
harm.
reduction
substance
abuse
misuse
avian influenza
AIV
bird flu
screening
surveillance
saliva
H5N1
H7N1
H7N3
Flu A
Flu B
influenza A
influenza B
influenza
women's health
sepsis
Group B Strep
Group B Streptococcus
Streptococcus

Contracts

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for BIOSYNCHRONICITY CORPORATION lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

BELLE-VIEW OFFICE PARK

325 118TH AVENUE SE, STE 210

BELLEVUE, WA, 98005

USA

Mailing Address

11410 NE 124TH ST PO BOX 121

KIRKLAND, WA, 98034

USA

Government Business Contact

Muriel Wood

325 118th Ave SE

Ste 210

Bellevue, WA, 98005

USA

Electronic Business Contact

MURIEL WOOD

325 118th Ave SE

Ste 210

Bellevue, WA, 98005

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

BIOSYNCHRONICITY CORPORATION has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires June 5, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Registered for disaster relief contracting

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization
Organization:Manufacturer of Goods

Registration Details

Source: SAM.gov

Initial Registration

Aug 7, 2020

Last Update

Jun 18, 2026

Registration Activation

Active — Jun 18, 2026

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

01